Ascendent Capital Partners

General contacts

Investor type

Founded

AUM

Location

Hong Kong, Hong Kong, Hong Kong

Investment Ticket

$50-100 m

Investment Stage

Series A Series B Late Stage (Series C+)

Region of investment

Asia

Investor profile last updated: 27 August, 2026

Profile

Ascendent Capital Partners is a private equity investment management firm based in Hong Kong, founded by Leon Meng, a former Managing Director at D. E. Shaw & Co. The firm is composed of senior members with extensive experience in international financial institutions, focusing on leveraging strategic resources and professional judgment to execute private equity investments and advisory transactions within China and globally. Ascendent Capital Partners is known for its strong relationships with entrepreneurs in the Greater China region.

The firm targets investment opportunities related to Greater China, managing funds for globally renowned institutional investors such as sovereign wealth funds, endowments, pensions, and foundations. Ascendent Capital Partners invests across sectors like healthcare technology systems and services, financial services, and other industries, helping portfolio companies to realize strategic transformations and create higher value. The firm manages funds such as Ascendent Capital Partners II, a $600 million growth and expansion fund launched in 2015.

Notable investments by Ascendent Capital Partners include Best Assistant - educational software, SciClone Pharmaceuticals - drug discovery, and BioChain Beijing - diagnostic equipment. These investments highlight the firm's focus on innovative and groundbreaking transactions across diverse sectors tied to China and the Asia-Pacific region.

Industry

Healthcare Services Financial Services Education Consumer Products Business Services (B2B) Telecommunications Pharmaceuticals Industrial

Ascendent Capital Partners Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
Ascendent Capital Partners II	Private Equity (PE)	Healthcare Services Financial Services Education Consumer Products Business Services (B2B) Telecommunications Pharmaceuticals Industrial	Series A Series B Late Stage (Series C+)	Asia	$10-50 m	$600 M	January 2015

Contacts

Name

Title

Social Networks

Leon Meng Founding Managing Partner and CEO

Founding Managing Partner and CEO

l•••@•••

Liang Meng Co-Founder & Managing Partner

Co-Founder & Managing Partner

l•••@•••

Upgrade to see contacts

lH9g254pEBaM1Qkd lH9g254pEBaM1Qkd

lH9g254pEBaM1Qkd

[email protected]

lH9g254pEBaM1Qkd lH9g254pEBaM1Qkd

lH9g254pEBaM1Qkd

[email protected]

lH9g254pEBaM1Qkd lH9g254pEBaM1Qkd

lH9g254pEBaM1Qkd

[email protected]

Investment-team contacts for Ascendent Capital Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Ascendent Capital Partners

Is Ascendent Capital Partners a venture capital or private equity firm?

Ascendent Capital Partners is a private equity firm. It backs companies at Series A, Series B and Late Stage (Series C+), writing tickets of $50-100 m.

Where is Ascendent Capital Partners located?

Ascendent Capital Partners is located in Hong Kong, Hong Kong, Hong Kong.

When was Ascendent Capital Partners founded?

Ascendent Capital Partners was founded in .

What sectors and industries does Ascendent Capital Partners invest in?

Ascendent Capital Partners invests in companies and startups in Healthcare Services, Financial Services, Education, Consumer Products, Business Services (B2B), Telecommunications, Pharmaceuticals, Industrial.

What is Ascendent Capital Partners geographical focus of investments?

Ascendent Capital Partners invests in companies and startups in Asia.

At what stages of companies and startups does Ascendent Capital Partners typically invest in?

Ascendent Capital Partners invests in companies and startups at Series A, Series B, Late Stage (Series C+).

What is the usual amount of Ascendent Capital Partners investment?

Ascendent Capital Partners usually invests $50-100 m on average.

What are the contacts of Ascendent Capital Partners?

Ascendent Capital Partners can be reached through its website ascendentcp.com/en and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Ascendent Capital Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access Ascendent Capital Partners data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Ascendent Capital Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the Ascendent Capital Partners profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 27 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.